PMC:7536954 / 838-988 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T19","span":{"begin":27,"end":29},"obj":"Disease"},{"id":"T20","span":{"begin":34,"end":37},"obj":"Disease"},{"id":"T21","span":{"begin":52,"end":60},"obj":"Disease"},{"id":"T22","span":{"begin":61,"end":70},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0006559"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0007915"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"We report one patient with HS and SLE who developed COVID‐19 infection during treatment with off‐label secukinumab associated with hydroxychloroquine."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T12","span":{"begin":97,"end":102},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"We report one patient with HS and SLE who developed COVID‐19 infection during treatment with off‐label secukinumab associated with hydroxychloroquine."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":27,"end":29},"obj":"Chemical"},{"id":"T10","span":{"begin":97,"end":102},"obj":"Chemical"},{"id":"T11","span":{"begin":131,"end":149},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_74056"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"We report one patient with HS and SLE who developed COVID‐19 infection during treatment with off‐label secukinumab associated with hydroxychloroquine."}

{"project":"LitCovid-PubTator","denotations":[{"id":"32","span":{"begin":14,"end":21},"obj":"Species"},{"id":"35","span":{"begin":131,"end":149},"obj":"Chemical"},{"id":"44","span":{"begin":34,"end":37},"obj":"Disease"},{"id":"45","span":{"begin":52,"end":60},"obj":"Disease"},{"id":"46","span":{"begin":61,"end":70},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:9606"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:D006886"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D008180"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:C000657245"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We report one patient with HS and SLE who developed COVID‐19 infection during treatment with off‐label secukinumab associated with hydroxychloroquine."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T12","span":{"begin":27,"end":29},"obj":"Phenotype"},{"id":"T13","span":{"begin":34,"end":37},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0040154"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0002725"}],"text":"We report one patient with HS and SLE who developed COVID‐19 infection during treatment with off‐label secukinumab associated with hydroxychloroquine."}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":0,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We report one patient with HS and SLE who developed COVID‐19 infection during treatment with off‐label secukinumab associated with hydroxychloroquine."}